Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks
Clinical trial NCT02914184 · COMPLETED
Trial details
- NCT number
- NCT02914184
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-27
- Primary completion
- 2018-06-27
- Enrollment
- 1612
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.